120205-56-3

Basic information

• Product Name: benzyl methyl[(2S,3S)-3-methyl-1-oxopentan-2-yl]carbamate
• Synonyms: benzyl methyl[(2S,3S)-3-methyl-1-oxopentan-2-yl]carbamate
• CAS NO: 120205-56-3
• Molecular Weight: 263.337
• Mol File: 120205-56-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: benzyl methyl[(2S,3S)-3-methyl-1-oxopentan-2-yl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl methyl[(2S,3S)-3-methyl-1-oxopentan-2-yl]carbamate(120205-56-3)
• EPA Substance Registry System: benzyl methyl[(2S,3S)-3-methyl-1-oxopentan-2-yl]carbamate(120205-56-3)

Safety Data

• Hazardous Substances Data: 120205-56-3(Hazardous Substances Data)

Upstream product

• 120205-55-2 N-Z-N-Me-(S,R)-isoleucinol 
• 3160-59-6 N-benzyloxycarbonyl-isoleucine 
• 319-78-8 isoleucine 
• 163887-30-7 N-Z-N-Me-(S,R)-Ile 
• 501-53-1 benzyl chloroformate 
• 120205-55-2 benzyl [(2S,3S)-1-hydroxy-3-methylpentan-2-yl]methylcarbamate 
• 3160-59-6 N-Cbz-L-Isoleucine 
• 42417-66-3 (2S,3S)-3-methyl-2-(methyl{[(phenylmethyl)oxy]carbonyl}amino)pentanoic acid 

Downstream Products

• 177659-48-2 [(1S,2R,3S)-1-((S)-sec-Butyl)-2-hydroxy-4-((S)-4-isopropyl-2-oxo-oxazolidin-3-yl)-3-methylsulfanyl-4-oxo-butyl]-methyl-carbamic acid benzyl ester 
• 716371-48-1 (1R)-2-endo-[(3R,4S,5S)-4-(N-benzyloxycarbonyl-N-methylamino)-3-hydroxy-5-methylheptanoyl]-2-exo-trimethylsilyloxy-1,7,7-trimethylbicyclo[2.2.1]heptane 
• 1438853-29-2 N-{(2R,3R)-3-methoxy-3-[(2S)-1-{(3R,4S,5S)-3-methoxy-5-methyl-4-[methyl(L-valyl)amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl]-L-phenylalanine 
• 1438852-80-2 pentafluorophenyl (3R,4S,5S)-4-[{N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl}(methyl)amino]-3-methoxy-5-methylheptanoate 
• 1438852-21-1 methyl (S)-2-((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanamido)-3-phenylpropanoate 
• 120205-58-5 tert-Butyl (3R,4S,5S)-3-methoxy-4--5-methylheptanoate 

Relevant articles and documents

CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF

The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.

The dolastatins. 19. Synthesis of dolaisoleuine

The synthesis of dolaisoleuine as its tert-butyl ester (Dil-OBu(t)), a β- methoxy-γ-amino acid component of dolastatin 10, has been achieved employing as key step an aldol condensation between N-(benzyloxycarbonyl)-N-methyl- (S,S)-isoleucinal and tert-butyl acetate followed by O-methylation. The overall six-step reaction sequence to Dil proved to be convenient for routine preparation of this new amino acid and its stereochemical assignment as (3R,4S,5S)-N,O-dimethylisostatine.

The absolute configuration and synthesis of natural (-)-dolastatin 101

-